Claude Galphin

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle

Prabir Roy‐Chaudhury, Jim A. Tumlin, Bruce A. Koplan et al. · Kidney International · 2018 · 191 citations · Full text

Heart Failure, Sudden Death, Serum Chemistries +20

Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis

Julia B. Lewis, Mohammed Sika, Mark J. Koury et al. · Journal of the American Society of Nephrology · 2014 · 187 citations · Full text

Active Control Period, Hemodialysis, Urology +13

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 111 citations · Full text

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury

James A. Tumlin, Claude Galphin, Ashita Tolwani et al. · PLoS ONE · 2015 · 61 citations · Full text